Skip to main content
Log in

Syndemic of Substance Abuse, Depression, and Type 2 Diabetes and Their Association with Retention in Care Among People Living with HIV

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Substance abuse (SA), depression, and type 2 diabetes (DM2) often co-occur among people living with HIV (PLHIV). Guided by a syndemic framework, this cross-sectional retrospective study examined the cumulative and interaction effects of SA, depression, and DM2 on retention in HIV care (RIC) among 621 PLHIV receiving medical care in central Pennsylvania. We performed logistic regression analysis to test the associations between SA, depression, and DM2 and RIC. To test the “syndemic” model, we assessed additive and multiplicative interactions. In an unadjusted model, a dose-response pattern between the syndemic index (total number of health conditions) and RIC was detected (OR for 1 syndemic factor vs. none: 1.01, 95% CI: 0.69–1.47; 2 syndemic factors: 1.59, 0.89–2.84; 3 syndemic factors: 1.62, 0.44–5.94), but no group reached statistical significance. Interactions on both additive and multiplicative scales were not significant, demonstrating no syndemic effect of SA, depression, and DM2 on RIC among our study sample. Our findings highlight that comorbid conditions may, in some populations, facilitate RIC rather than act as barriers, which may be due to higher levels of engagement with medical care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

The datasets used and/or analyzed during the current study are available from the Penn State College of Medicine.

Code Availability

Not applicable.

References

  1. CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas., 2019. HIV Surveill Suppl Rep. 2021 [cited 2022 May 22];26(2). Available from: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. http://wwwn.cdc.gov/dcs/ContactUs/Form

  2. Baeten JM, Donnell D, Ndase P et al. Antiretroviral prophylaxis for hiv prevention in heterosexual men and women. N Engl J Med. 2012 [cited 2022 Feb 9];367(5):399–410. Available from: https://www.nejm.org/doi/full/https://doi.org/10.1056/nejmoa1108524

  3. Crawford TN, Thornton A. Retention in continuous care and sustained viral suppression: examining the association among individuals living with HIV. In: Journal of the International Association of Providers of AIDS Care. SAGE Publications Inc.; 2017 [cited 2020 Aug 11]. p. 42–7. Available from: http://journals.sagepub.com/doi/https://doi.org/10.1177/2325957416678929

  4. Crepaz N, Tang T, Marks G, Mugavero MJ, Espinoza L, Hall HI. Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012–2013. Clin Infect Dis. 2016 [cited 2020 Nov 14];63(7):976–83. Available from: /pmc/articles/PMC5021630/?report=abstract.

  5. Abebe Moges N, Olubukola A, Micheal O, Berhane Y. HIV patients retention and attrition in care and their determinants in Ethiopia: a systematic review and meta-analysis. Vol. 20, BMC Infectious Diseases. BioMed Central Ltd; 2020 [cited 2022 Feb 20]. p. 1–24. Available from: https://bmcinfectdis.biomedcentral.com/articles/https://doi.org/10.1186/s12879-020-05168-3

  6. Bulsara SM, Wainberg ML, Newton-John TRO. Predictors of adult retention in HIV care: a systematic review. Vol. 22, AIDS and Behavior. Springer New York LLC; 2018 [cited 2020 Oct 31]. p. 752–64. Available from: /pmc/articles/PMC5476508/?report=abstract

  7. Krentz HB, McPhee P, Arbess G, et al. Reporting on patients living with HIV disengaging from care. Who is actually lost to follow-up? AIDS Care - Psychol Socio-Medical Asp AIDS/HIV; 2020. 0121(May).

  8. Ghiam MK, Rebeiro PF, Turner M et al. Trends in HIV continuum of care outcomes over ten years of follow-up at a large HIV primary medical home in the Southeastern United States. AIDS Res Hum Retroviruses. 2017 [cited 2020 Oct 6];33(10):1027–34. Available from: /pmc/articles/PMC5650719/?report=abstract.

  9. Smith LR, Fisher JD, Cunningham CO, Amico KR. Understanding the behavioral determinants of retention in hiv care: a qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and maintenance. AIDS Patient Care STDS. 2012;26(6):344–55.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Zuniga JA, Yoo-Jeong M, Dai T, Guo Y, Waldrop-Valverde D. The role of depression in retention in care for persons living with HIV. AIDS Patient Care STDS. 2016;30(1):34–8.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials. 2009;10(5):299–305.

    Article  PubMed  Google Scholar 

  12. Reveles KR, Juday TR, Labreche MJ et al. Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients. De Socio GV, editor. PLoS One. 2015 [cited 2020 Oct 6];10(3):e0120953. https://doi.org/10.1371/journal.pone.0120953

  13. Durvasula R, Miller TR. Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis. Behav Med. 2014 [cited 2021 Jan 28];40(2):43–52. Available from: /pmc/articles/PMC3999248/?report=abstract.

  14. Korthuis PT, Edelman EJ. Substance use and the HIV care continuum: important advances. Addict Sci Clin Pract. 2018 [cited 2021 Jan 6];13(1):13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848588/

  15. Remien RH, Stirratt MJ, Nguyen N, Robbins RN, Pala AN, Mellins CA. Mental health and HIV/AIDS: the need for an integrated response. AIDS. 2019;33(9):1411–20.

    Article  PubMed  Google Scholar 

  16. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. Vol. 142, J Affect Disord. 2012.

  17. Tsuyuki K, Pitpitan EV, Levi-Minzi MA et al. Substance use disorders, violence, mental health, and HIV: differentiating a syndemic factor by gender and sexuality. AIDS Behav. 2017 [cited 2020 Dec 11];21(8):2270–82. Available from: https://uknowledge.uky.edu/chsr_facpub

  18. Cole MB, Galárraga O, Rahman M, Wilson IB. Trends in comorbid conditions among medicaid enrollees with HIV. Open Forum Infect Dis. 2019 [cited 2020 Oct 18];6(4). Available from: https://academic.oup.com/ofid/article/6/4/ofz124/5372988

  19. Hartzler B, Dombrowski JC, Crane HM et al. Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS Behav. 2017 [cited 2021 Mar 24];21(4):1138–48. Available from: /pmc/articles/PMC6089366/.

  20. Do AN, Rosenberg ES, Sullivan PS et al. Excess burden of depression among HIV-infected persons receiving medical care in the United States: data from the medical monitoring project and the behavioral risk factor surveillance system. Zheng JC, editor. PLoS One. 2014 [cited 2020 May 5];9(3):e92842. https://doi.org/10.1371/journal.pone.0092842

  21. Duncan AD, Goff LM, Peters BS. Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study. PLoS One. 2018 [cited 2020 Oct 27];13(3). Available from: /pmc/articles/PMC5847234/?report=abstract

  22. Altice FL, Kamarulzaman A, Soriano VV, et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs HHS public access. Lancet. 2010;376(9738):367–87.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rooks-Peck CR, Adegbite AH, Wichser ME, et al. Mental health and retention in HIV care: a systematic review and meta-analysis. Heal Psychol. 2018;37(6):574–85.

    Article  Google Scholar 

  24. Zuniga JA, García AA, Lee J, Park J. Retention in care in aging adults with a dual diagnosis of HIV infection and type 2 diabetes mellitus: a longitudinal retrospective cross-sectional study. AIDS Res Ther. 2020 [cited 2020 Oct 30];17(1):29. Available from: /pmc/articles/PMC7260810/?report=abstract

  25. Yehia BR, Stephens-Shield AJ, Momplaisir F et al. Health outcomes of HIV-infected people with mental illness. AIDS Behav. 2015 [cited 2020 Sep 18];19(8):1491–500. Available from: /pmc/articles/PMC4527875/?report=abstract.

  26. Geldsetzer P, Vaikath M, Wagner R, et al. Depressive symptoms and their relation to age and chronic diseases among middle-aged and older adults in rural South Africa. Journals Gerontol - Ser A Biol Sci Med Sci. 2019;74(6):957–63.

    Article  Google Scholar 

  27. Singer M, Clair S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q. 2003;17(4):423–41.

    Article  PubMed  Google Scholar 

  28. Kuhns LM, Hotton AL, Garofalo R et al. An index of multiple psychosocial, syndemic conditions is associated with antiretroviral medication adherence among HIV-positive youth. AIDS Patient Care STDS. 2016 [cited 2020 Nov 1];30(4):185–92. Available from: /pmc/articles/PMC4827312/?report=abstract.

  29. Sileo KM, Kershaw TS, Callands TA. A syndemic of psychosocial and mental health problems in Liberia: examining the link to transactional sex among young pregnant women. Glob Public Health. 2019;14(10):1442–53. Available from: /pmc/articles/PMC6938027/?report=abstract.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Tsai AC, Burns BFO. Syndemics of psychosocial problems and HIV risk: a systematic review of empirical tests of the disease interaction concept. Vol. 139, Social Science and Medicine. 2015. p. 26–35.

  31. Friedman MR, Stall R, Silvestre AJ et al. Effects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort study. AIDS. 2015 [cited 2020 Dec 30];29(9):1087–96. Available from: http://journals.lww.com/00002030-201506010-00014

  32. Tsai AC, Venkataramani AS. Syndemics and health disparities: a methodological note. AIDS Behav. 2016 [cited 2020 Dec 11];20(2):423–30. Available from: /pmc/articles/PMC4755906/?report=abstract.

  33. Mugavero MJ, Westfall AO, Zinski A et al. Measuring retention in HIV care: the elusive gold standard. In: J Acquir Immune Defic Syndr. 2012. p. 574–80.

  34. HRSA. Core performance measures. 2019. Health Resources and Services Administration. 2019 [cited 2022 May 29]. Available from: https://hab.hrsa.gov/sites/default/files/hab/clinical-quality-management/coremeasures.pdf

  35. Anderson AN, Higgins CM, Haardörfer R, Holstad MMD, Nguyen MLT, Waldrop-Valverde D. Disparities in retention in care among adults living with HIV/AIDS: a systematic review. AIDS Behav. 2020;24(4):985–97. https://doi.org/10.1007/s10461-019-02679-2

  36. RuralHealthResearchCenter. Rural urban commuting area codes data. Rural Health Research Center. [cited 2022 Feb 4]. Available from: https://depts.washington.edu/uwruca/ruca-uses.php

  37. McDonald LR, Antoine DG, Liao C, Lee A, Wahab M, Coleman JS. Syndemic of lifetime mental illness, substance use disorders, and trauma and their association with adverse perinatal outcomes. J Interpers Violence. 2020 [cited 2021 Jan 17];35(1–2):476–95. Available from: http://journals.sagepub.com/doi/https://doi.org/10.1177/0886260516685708

  38. Farhadian M, Mohammadi Y, Mirzaei M, Shirmohammadi-Khorram N. Factors related to baseline CD4 cell counts in HIV/AIDS patients: comparison of poisson, generalized poisson and negative binomial regression models. BMC Res Notes. Dec. 2021;14(1). https://doi.org/10.1186/s13104-021-05523-w

  39. Min S, Gillani FS, Aung S, Garland JM, Beckwith CG. Evaluating HIV viral rebound among persons on suppressive antiretroviral treatment in the era of ‘undetectable equals untransmittable (U = U)’. Open Forum Infect Dis. Dec. 2020;7(12). https://doi.org/10.1093/ofid/ofaa529

  40. Chakrapani V, Lakshmi PVM, Tsai AC, Vijin PP, Kumar P, Srinivas V. The syndemic of violence victimisation, drug use, frequent alcohol use, and HIV transmission risk behaviour among men who have sex with men: cross-sectional, population-based study in India. SSM - Popul Heal. 2019;7:100348.

    Article  Google Scholar 

  41. Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1). https://doi.org/10.1186/s12874-017-0442-1

  42. Cerdá M, Sagdeo A, Johnson J, Galea S. Genetic and environmental influences on psychiatric comorbidity: a systematic review. Vol. 126, Journal of Affective Disorders. NIH Public Access; 2010 [cited 2021 Jan 28]. p. 14–38. Available from: /pmc/articles/PMC2888715/?report=abstract

  43. Kim Y, Kim K, Chartier KG, Wike TL, McDonald SE. Adverse childhood experience patterns, major depressive disorder, and substance use disorder in older adults. Aging Ment Heal. 2019 [cited 2021 Jan 28]; Available from: https://pubmed.ncbi.nlm.nih.gov/31769297/

  44. Diderichsen F, Andersen I, Mathisen J. Depression and diabetes: the role of syndemics in the social inequality of disability. J Affect Disord Reports. 2021;6:100211.

    Article  Google Scholar 

  45. Myers K, Li T, Baum M, Ibanez G, Fennie K. The individual, interactive, and syndemic effect of substance use, depression, education, and ethnicity on retention in HIV care. Int J STD AIDS. 2021;32(2):184–93.

    Article  PubMed  Google Scholar 

  46. Crawford TN. Examining the relationship between multiple comorbidities and retention in HIV medical care: a retrospective analysis. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. 2015;27(7):892–9.

    Google Scholar 

  47. Palamar JJ, Le A. Electronic health record data may lead to underestimates of cannabis use—especially among older populations. J Am Geriatr Soc. 2022;70(6):1657–60.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Christine Quimby for her important contributions to data cleaning.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

TBE conceived and designed the study, analyzed the data, and wrote the first draft of the manuscript. TBE, AH, CJW, LMC, WH, and KS, contributed to interpretation of data and read and approved the final manuscript.

Corresponding author

Correspondence to Tarek B. Eshak.

Ethics declarations

Conflicts of Interest

The authors declare that they have no conflict of interest.

Ethics Approval

This research was approved by the Penn State College of Medicine Institutional Review Board.

Consent to Participate

Not applicable.

Consent to Publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eshak, T.B., Hobkirk, A.L., Whitener, C.J. et al. Syndemic of Substance Abuse, Depression, and Type 2 Diabetes and Their Association with Retention in Care Among People Living with HIV. AIDS Behav 28, 1612–1620 (2024). https://doi.org/10.1007/s10461-024-04275-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-024-04275-5

Keywords

Navigation